In an apparent paradox, morbidity and mortality are lower in obese patients undergoing cardiac surgery, although the nature of this association is unclear. We sought to determine whether the obesity paradox observed in cardiac surgery is attributable to reverse epidemiology, bias, or confounding. 
I
n an apparent paradox, obesity, an important risk factor for cardiovascular death, 1,2 is associated with reduced mortality after cardiac surgery. 3 Similar observations have been described in patients with acute coronary syndromes 4 or heart failure 5 and those requiring dialysis. 6 It is unclear whether this simply reflects the limitations of epidemiological analyses or whether there may be actual protective factors associated with obesity that contribute to improved outcomes. The obesity paradox has been attributed to reverse epidemiology (causation) or collider bias whereby the survival benefit associated with obesity actually reflects worse outcomes in underweight patients who also have frailty, cachexia, or severe chronic disease. 7 Alternative hypotheses are that obese patients are selected for surgery only if they are subjectively at lower risk and have high body mass index (BMI) but no metabolic syndrome with its related complications. 8 We report the results of 2 related studies in patients undergoing cardiac surgery: a cohort study of UK and Ireland cardiac surgery audit data and a systematic review with meta-analysis of this and other similar studies that have considered the relationship between BMI and mortality. The aim of these studies was to assess whether the obesity paradox in cardiac surgery can be attributed to reverse epidemiology, bias and confounding, or other mechanisms.
METHODS Observational Study Cohort
Prospectively collected data were extracted from the National Adult Cardiac Surgery Audit (NACSA) registry (version 4.1.2) of the National Institute for Cardiovascular Outcomes Research on December 1, 2014, for all cardiac operations performed in the United Kingdom and Ireland. These data are collected prospectively and undergo robust validation and checking procedures to maintain data quality. [9] [10] [11] [12] Duplicate records and nonadult cardiac surgery entries were removed; transcriptional discrepancies were harmonized; and clinical and temporal conflicts and extreme values were corrected or removed. 11 No attempt to replace missing values was made. The need to obtain informed consent was waived because patients' identifiable information was either removed or pseudonymized. The study was approved by the National Institute for Cardiovascular Outcomes Research NACSA Research Board (study reference 14-ACS-29) and complies with the Strengthening the Reporting of Observational Studies in Epidemiology reporting requirements for observational studies (Appendix I in the online-only Data Supplement). 13 
Study Design
We performed a retrospective, observational cohort study encompassing all adult cardiac surgical procedures performed in the United Kingdom and Ireland between April 1, 2002 , and March 31, 2013. For each operation, data were recorded on patient characteristics and demographics, comorbidities, intraoperative factors, and postoperative outcomes. Administrative data were also extracted. The analysis data set was obtained by including all cases with complete data on a set of key preoperative, intraoperative, and postoperative variables as follows: age, BMI, sex, left ventricular ejection fraction category, history of myocardial infarction, renal impairment, diabetes mellitus on medication, previous cardiac surgery, operation type, and cardiopulmonary bypass use. Patients undergoing salvage surgical procedures (cardiac arrest before induction), patients with critical preoperative state (ventilated, cardiogenic shock, inotropic support, intra-aortic balloon pump), and patients with stage 5 chronic kidney disease (dialysis) were excluded. Patients for whom it was not possible to calculate the BMI or for whom the sex of the patient, operation type, or discharge status was missing were also excluded.
Study Outcomes, Exposures, and Confounding
BMI was defined as the weight in kilograms divided by the square of the height in meters.
14 According to the World Health Organization (WHO) classification, 15 BMI was further categorized into 6 classes: underweight (BMI <18.5 kg/m ). The primary end point was in-hospital mortality, defined as death in hospital after the index surgical procedure and before transfer from the cardiac surgery unit as per the definition used in the national audit. Potential confounders prespecified in our analyses included severe chronic disease: chronic lung
Clinical Perspective
What Is New?
• In a nationwide cohort study of 401 227 adult patients and a systematic review of 557 720 patients from 13 countries, we demonstrated that overweight and obese patients had improved outcomes after cardiac surgery compared with normalweight patients.
• Subgroup and sensitivity analyses designed to mitigate the effects of likely sources of bias and confounding did not affect our estimates that demonstrated reductions in mortality with increasing levels of obesity.
• Analysis of secondary outcomes indicated that obesity also had divergent associations with important causes of death.
What Are the Clinical Implications?
• The present findings do not support common practice whereby weight loss is recommended before surgery in the morbidly obese or very obese patients are refused surgery.
• These results suggest a new area for research into strategies that may minimize organ failure in cardiac surgery and other clinical settings characterized by acute surgical metabolic stress.
disease, chronic renal impairment, neurological dysfunction, and New York Heart Association class III/IV symptoms, as well as sex, increasing age, ejection fraction category, Canadian Cardiovascular Society class, diabetes mellitus, extracardiac arteriopathy, social deprivation index, and metabolic syndrome, a composite of increased BMI, hypertension, and diabetes mellitus. Secondary end points were low cardiac output, defined by the new use of an intra-aortic balloon pump postoperatively; re-exploration for bleeding/tamponade; postoperative stroke; severe acute kidney injury, defined as need for new postoperative renal replacement therapy (RRT); and occurrence of deep sternal wound infection. Variables and outcomes were defined according to the NACSA registry.
10
Systematic Review and Meta-Analysis
The review protocol was developed, and complete details, including electronic search strategy, objectives, criteria for study selection, eligibility, data collection, and assessment of study quality, were published online and registered in PROSPERO (CRD42015024232). 16 The review adhered to MOOSE (MetaAnalysis of Observational Studies in Epidemiology) and PRISMA (Preferred Reporting Items for Systematic Reviews and MetaAnalyses) guidelines (Appendixes II and III in the online-only Data Supplement). 17, 18 Briefly, literature searches were systematically performed with electronic databases (MEDLINE [PubMed and Ovid], Embase, SCOPUS, and Cochrane Library) without date or language restriction from inception to the end of June 2015. Key words and MeSH terms pertinent to the exposure of interest were used in relevant combinations: body mass index, obesity, overweight, underweight, cardiac surgery, adult, coronary artery bypass grafting, valve surgery, aortic surgery, cardiac transplant, ventricular assist device, mortality, morbidity, and patient outcome. References of all eligible studies and review articles were also screened to identify relevant resources that were not previously identified. The exposure of interest was obesity stratified into the 6 BMI groups according to the WHO classification. 15 Studies with alternative BMI definitions of the underweight class were also included and defined as modified WHO classification. All adult cardiac surgical procedures were considered. Studies in which BMI was expressed as a continuous variable or in which BMI classes were merged were excluded. The primary outcome of interest was all-cause mortality in hospital or within 30 days from the index admission or procedure. Inclusion and exclusion criteria for qualitative/quantitative analyses were summarized according to the PICOS (population, intervention, comparator, outcomes, and study design) approach (Table I in the onlineonly Data Supplement). Year of publication, study design, country, sample size, recruitment period, number of patients in each treatment group, inclusion and exclusion criteria, measured outcomes, obesity classification, baseline patient demographics, cardiac status, comorbidities, and outcomes among relevant subgroups of patients were extracted. The Newcastle-Ottawa Scale for cohort and case-control studies was used to assess study quality. 19 
Statistical Analysis
Statistical analysis methods are fully reported in the online-only Data Supplement. Briefly, baseline characteristics, operative factors, and univariate outcomes were described as median (25th-75th percentiles) and counts and percents and compared among BMI groups with the Kruskal-Wallis test and the χ 2 test, respectively. To adjust the effect of BMI (6 categories) for potential confounders, multivariable logistic regression models of the primary and secondary outcomes were fitted. Sensitivity analyses evaluated the effects of inclusion or exclusion of suggested confounders identified in previous analyses of the obesity paradox. 3, Subgroup analyses assessed the interaction in the full model between prespecified known risk factors for adverse outcomes in cardiac surgery and the associations between BMI and mortality. Propensity score analysis (propensity for being overweight) was also performed. Effect estimates were presented as odds ratios (ORs) and 95% confidence intervals (CIs). Stata version 13.1 (StataCorp, College Station, TX) was used for computation. The meta-analysis was performed with R version 3.2.2 (R Core Team, 2015) with the metafor package version 1.9-8. 45, 46 Random/mixed-effects models were adopted to summarize the results expressed as relative risks (95% CIs). 47, 48 The contribution of study-level covariates to heterogeneity was assessed with mixed-effects models. Publication bias was assessed with funnel plots and the Egger test. 49 Statistical tests were 2 sided with a significance threshold of P<0.05.
RESULTS

Observational Study Cohort
Of the 401 227 records identified in the NACSA registry, 350 800 (87.4%) had complete case data and were included in the analysis data set. The final cohort presented a median age of 59 years (25th-75th percentile, 18-67 years), and 27% were women. Median BMI was 27.5 kg/m 2 (25th-75th percentile, 24.8-30.7 kg/m 2 ), and 3382 patients (1%) were classified as underweight, 91 378 (26%) as normal weight, 150 769 (43%) as overweight, 77 614 (22%) as obese class I, 21 610 (6%) as obese class II, and 6047 (2%) as obese class III. Preoperative and operative characteristics are summarized in the Table. 50,51 Patients with higher BMI were younger and had a higher prevalence of hypertension and diabetes mellitus. A higher prevalence of women was observed in the underweight and the morbidly obese groups. Key variable comparison of the cohort with incomplete data to the complete case cohort suggested that the missing-at-random mechanism was applicable ( Table II in 
Primary End Point
Overall, 11 511 patients died in hospital (3.29%; 95% CI, 3.23-3.34). Mortality was 8.5% in underweight patients, 4.4% in normal-weight patients, 2.7% in overweight patients, 2.8% in obese class I to II patients, and 3.7% in obese class III patients (Table III in the online-only Data Supplement). This U-shaped relationship was confirmed after adjustment for baseline differences ( Figure 1A ). (7) 459 (15) 7296 (9) 8863 (6) 3915 (6) 1020 (5) 264 (5) 0.0001 0.0001 Intravenous nitrates 17 389 (5) 224 (1) 5025 (6) 7355 (5) 3517 (5) 947 (4) 321 (5) (35) 2445 (41) Class IV 20 077 (6) 417 (12) 6362 (7) 7489 (5) 3883 (5) 1415 (7) 511 (9) CCS class III/IV 113 168 (33) 667 (20) Multiple additional baseline predictors of mortality differed in frequency across the BMI groups (Table IV in the online-only Data Supplement). After adjustment for differences in baseline risk, the OR for hospital mortality was 1.51 (95% CI, 1.41-1.62) for underweight versus normal-weight patients (Tables III and IV in 
Sensitivity and Subgroup Analyses
Fractional polynomial, restricted cubic spline, and propensity score analyses demonstrated findings similar to our primary analysis (Tables IV and V and Figure I in the online-only Data Supplement). Sensitivity analyses that excluded patients with low BMI (underweight patients), poor exercise tolerance (New York Heart Association class III/IV), and severe chronic cardiac, neurological, renal, or respiratory diseases also did not materially alter our findings ( Figure 1B) . Analyses of subgroup interactions indicated that the relative reductions in mortality in obese/overweight patients versus normal-weight indi- score is a calculated deprivation score for geographical area inhabited by at least 1000 people and is used for investigating social deprivation and cardiovascular disease outcomes. The IMD score is based on income deprivation; employment deprivation; health deprivation and disability; education, skills, and training deprivation; barriers to housing and services; crime and disorder; and living environment. Figure 1 . Probability of in-hospital mortality among enrolled patients according to body mass index (BMI) class. Bars represent the effect estimate probability with 95% confidence intervals.
A, Results for the total study population. B, Results of the analysis excluding underweight patients, underweight patients (Continued ) viduals were less in patients with atrial fibrillation, chronic lung disease, kidney disease, or poor left ventricular function (Figure 1C-1E and Table VI and Figure II in the online-only Data Supplement). In contrast, the protective associations seen with obesity were greater in older patients and in those with coronary disease undergoing coronary artery bypass grafting, extracardiac arteriopathy, or the metabolic syndrome ( Figure 1F-1H and Table  VI and Figure II in the online-only Data Supplement). The interaction between smoking status, BMI, and mortality was statistically significant but demonstrated mixed increases and decreases in odds of death by BMI class for each smoking category; never smoker, ex-smoker, and current smoker. Nonetheless, each category demonstrated a U-shaped relationship between BMI and mortality as per the primary analyses. The differences in mortality between obesity classes were also consistent over time (Table VI in the online-only Data Supplement).
Secondary End Points
To explore processes that could underlie the results of our primary analysis, we also evaluated the associations between BMI and important causes of death. Low cardiac output was observed in 3155 patients (1.0%), re-exploration for bleeding/tamponade in 14 509 (4.6%), stroke in 3120 (1.0%), RRT in 10 814 (3.6%), and deep sternal wound infection in 681 (0.2%; Table III in the online-only Data Supplement). Similar to the primary end point of hospital mortality, a U-shaped relationship was demonstrated between increasing BMI class and postoperative RRT and stroke ( Figure 2 ). An inverse U shape was observed for low cardiac output (postoperative intra-aortic balloon pump). In contrast, the rate of re-exploration for bleeding/tamponade decreased stepwise with increasing BMI, whereas the rate of deep sternal wound infection increased with BMI class. These relationships were not altered after adjustment for baseline differences. Additional analyses are reported in the Results section in the online-only Data Supplement.
Systematic Review and Meta-Analysis
Of the 4788 records identified by our searches, 26 eligible cohort observational studies were identified and included in the meta-analysis ( Figure III in the online-only Data Supplement). 8, When the data from the NACSA registry were included, the final meta-analysis population comprised 557 720 patients. Regions of origin of participants included Europe (n=14), the United States (n=9), and Asia (n=3), and patients from 13 countries were included (Table VII in 31, 36, 37 Newcastle Ottawa Scale assessment of study quality is reported in Table  XII in the online-only Data Supplement.
As per our cohort study, we demonstrated the obesity paradox in our meta-analysis. Compared with normal-weight patients, the observed relative risks were 0.73 (95% CI, 0.66-0.81) for overweight, 0.76 (95% CI, 0.67-0.86) for obese class I, 0.65 (95% CI, 0.60-0.71) for obese class II, and 0.83 (95% CI, 0.74-0.94) for obese class III patients (Figures 3 and  4) . Underweight patients had significantly increased mortality (relative risk, 1.77; 95% CI, 1.30-2.42) compared with normal-weight individuals (Figure 3) . Sensitivity analyses showed that the survival benefit for overweight/obese patients was greater when studies with significant methodological limitations (NewcastleOttawa Scale score <8) or studies that used modified WHO definitions of obesity were excluded (Table XIII in the online-only Data Supplement). Subgroup analysis demonstrated that the reductions in mortality with increasing obesity were greatest in patients undergoing isolated coronary artery bypass grafting compared with other types of surgical procedure (Figures 3 and  4) . Funnel plots revealed no evidence of publication bias in any of the mortality comparisons ( Figure IV in the online-only Data Supplement). Between-study heterogeneity was statistically significant in the analyses of normal-weight versus overweight patients Figure 1 Continued. or those with chronic disease, and patients with New York Heart Association (NYHA) class III/IV. C, Results of the analysis according to the ejection fraction (EF) category (P for interaction 0.004). D, Results of the analysis according to the presence of chronic lung disease (P for interaction <0.001). E, Results of the analysis according to the presence of chronic kidney disease (P for interaction <0.001). F, Results of the analysis according to the presence of metabolic syndrome (P for interaction <0.001). G, Results of the analysis according to the presence of coronary artery bypass graft (CABG) operation performed (P for interaction <0.001). H, Results of the analysis by age group (P for interaction <0.001).
(I 2 =62.3%, Q=59.99, P<0.001) and in normal-weight versus obese class I patients (I 2 =62.1%, Q=42.25, P<0.001). Meta-regression analysis identified several covariates that contributed to the observed heterogeneity, although a significant model effect was observed only in the obese class I comparison with reference to the average age and the use of the modified WHO classification for BMI (age: R 2 =82.35%, P=0.005; Figure 2 . Probability of secondary outcomes among enrolled patients according to body mass index (BMI) class.
Bars represent the effect estimate probability with 95% confidence intervals. The likelihood ratio test for linearity of risk is shown. As the null hypothesis assumes linearity, a significant P value (<0.05) rejects the linearity of risk hypothesis. DSWI indicates deep sternal wound infection; IABP, intra-aortic balloon pump; and RRT, renal replacement therapy. 
DISCUSSION
In large cohorts of UK and Irish patients undergoing cardiac surgery, we found that overweight and obese patients had lower in-hospital mortality compared with normal-BMI patients, whereas underweight patients had increased mortality. This relationship was unchanged when patients with low BMI, severe chronic disease, or severe limitation of exercise tolerance were excluded. Reductions in mortality associated with increasing BMI class were greater in older patients and in those with clinical complications of obesity. The relationship between obesity and secondary outcomes demonstrated heterogeneity; obesity was associated with a reduction of primarily ischemic complications such as low cardiac output and stroke but not RRT or infections. In a systematic review of 27 studies that included patients from 13 countries, we observed similar results. Subgroup and meta-regression analyses also demonstrated greater reductions in mortality associated with obesity in the elderly and in patients with coronary artery disease.
Our cohort study was significantly larger than all previous evaluations of the obesity paradox in cardiac surgery combined. We used high-quality, prospectively collected data that are used as part of a national quality control program in UK and Irish cardiac surgery. The study cohort included all patients undergoing cardiac surgery in every UK and Irish unit. Our analysis population included 87.4% of all patients, and we demonstrated that data missingness was likely to be random, reducing the likelihood of sampling bias. The study limitations were those of any retrospective analysis, notably the likelihood that unmeasured confounders will have introduced unknown bias. For example, it is possible that obese patients with a more severe profile of comorbidities and considered at high risk for a cardiac operation were excluded from surgery. The sample size of the cohort will have mitigated this source of bias because there were large numbers of patients with significant comorbidity in each BMI group, thereby allowing accurate estimation of the interaction between obesity and known risk factors for adverse outcome. The use of BMI as a marker of obesity also has significant limitations, and other important aspects of body composition such as visceral fat or fat distribution were not explored.
Our systematic review had important strengths. We used a comprehensive search strategy and contemporary assessments of study quality. We found that 17 of 27 studies had significant limitations. Studies of low quality and those that used nonstandard definitions of obesity were more likely to conclude that there was no obesity paradox. We also used detailed statistical methods to explore the independent contribution of potential confounders. This demonstrated that risk factors contributing to heterogeneity in the analysis of underweight patients (chronic lung disease and history of myocardial infarction) differed from those contributing to heterogeneity in the analyses of the obese (age and coronary artery disease). The meta-analysis also had limitations. Principally, the analysis relied on the reported information on confounding variables that were controlled for; consistent analyses of all studies can be done only when data on individual patients are combined. A limitation is that our studies consider data with a different time interval (March 2013 versus December 2015). The NACSA registry allowed us to collect and analyze validated data through March 2013 only. 10, 11 Another limitation of both analyses is that they considered only short-term mortality. Given that obesity is a principal etiologic factor in cardiovascular disease and premature death, 1, 52, 53 it is possible that early reductions in mortality observed in obese patients may not be sustained in the midterm to long-term. This has been reported in a previous study in which the short-term reduction in mortality observed in overweight and obese patients was no longer evident at 5 years. 54 Acute weight loss is also known to reduce major adverse cardiovascular event rates in patients with coronary artery disease in the longer term. 55, 56 A final limitation is that observational analyses, including in the present study, cannot prove or disprove the reverse epidemiology hypothesis for the obesity paradox; greater survival benefit attributable to increasing weight may equally represent increased mortality with lower body mass. It is intuitive that cachexia in cardiac patients, commonly associated with chronic diseases affecting the heart, lung, and kidneys, will contribute to adverse outcomes. 57 Alternatively, patients with severe Figure 3 Continued. For each patient subgroup, the asterisk denotes a statistically significant difference between the considered weight (Continued ) symptomatic coronary artery disease in the absence of obesity may represent a more aggressive phenotype and consequently have a worse outcome. However, both subgroup and sensitivity analyses suggested that patients with low BMI (<18.5 kg/m 2 ) or severe chronic lung, cardiac, neurological, or renal disease did not explain our findings. In fact, the effect of increasing obesity, or inversely lower body mass, on mortality was significantly less in these groups. This is in complete contrast to the interactions observed for increasing age, metabolic syndrome, and atherosclerotic disease. We also observed heterogeneity in the relationships between BMI and the principal causes of in-hospital death in cardiac surgery. These are key findings. If the relationship between obesity and mortality were simply the result of reverse epidemiology or confounding, then it would be expected that there would be a consistent effect on the estimate of the association between BMI and mortality across all risk factors for adverse outcome or important causes of death. A common example of this phenomenon is red cell transfusion, which is strongly associated with mortality and all important causes of mortality in cardiac surgery in cohort studies but has different and divergent effects on these events in randomized trials that consider causation. 58, 59 These findings highlight knowledge gaps that must be addressed by further research. They identify a highrisk cohort, patients with low BMI, who could potentially benefit from targeted weight gain interventions before surgery. They also challenge current practice whereby obese patients are rejected for or advised to lose weight before major surgery. The present analyses included large cohorts of obese class III (BMI ≥40 kg/ m 2 ) patients who are considered to have significantly higher morbidity and mortality and to use significantly more resources than other patient groups. 60 However, neither the National Institute for Cardiovascular Outcomes Research analysis nor the systematic review demonstrated an increase in mortality in these patients relative to normal-weight individuals. Divergent associations between obesity and important causes of death were most marked in this group; obese class III patients had less perioperative cardiac failure or bleeding but higher rates of deep sternal wound infection and RRT. The overall effects on resource use remain unclear because the National Institute for Cardiovascular Outcomes Research does not capture resource use data. Further research should consider whether strategies focused on the prevention of wound infection or acute kidney injury will have specific benefits in these morbidly obese patients.
CONCLUSIONS
We explored the basis of the obesity paradox in 2 related studies in patients undergoing cardiac surgery. Mitigation of the effects of potential bias and confounding did not substantially affect our estimates that demonstrated reductions in mortality with increasing levels of obesity. Moreover, analysis of subgroup interactions and secondary outcomes did not support a reverse epidemiology hypothesis. These findings highlight a knowledge gap with respect to the perioperative management of body mass and obesity in patients undergoing cardiac surgery. Figure 4 Continued. categories. AHA indicates American Heart Association (definition of body mass index [BMI] class); All, all types of cardiac operations; CABG, coronary artery bypass grafting; CI, confidence interval; iCABG, isolated coronary artery bypass grafting; mWHO, modified World Health Organization; NACSA, National Adult Cardiac Surgery Audit; NOS, New Ottawa Scale; RE, random effect; sWHO, standard World Health Organization; VAD, ventricular assist device; and WHO, World Health Organization (definition of BMI class).
